Abstract
Decreased diffusing capacity of the lung for carbon monoxide (DLCO) is observed in some idiopathic pulmonary arterial hypertension (IPAH) patients, but its clinical significance is uncertain. We aimed to assess clinical correlates and prognostic significance of low DLCO in IPAH patients. In the group of 65 IPAH patients the cut off value for low DLCO was set up based on histogram as < 55% of predicted value. Demographic data, exercise capacity, lung function tests, hemodynamic parameters and survival of the patients were compared depending on DLCO value. Low DLCO was found in 18% of the patients, and it was associated with male sex, older age, worse functional status and exercise capacity, and higher prevalence of coronary artery disease. Low DLCO carried a 4-fold increase of death risk in 5-year perspective. Low DLCO was a marker of worse functional capacity and increased risk of death in studied IPAH patients.
Highlights
Decreased diffusing capacity of the lung for carbon monoxide (DLCO) is observed in some idiopathic pulmonary arterial hypertension (IPAH) patients, but its clinical significance is uncertain
Diffusing capacity of the lung for carbon monoxide (DLCO) impairment has been already described in pulmonary arterial hypertension (PAH), mainly in connective tissue disease with both interstitial and vascular lung pathology [12−14]
In the remaining patients no parenchymal lesions were described on chest High resolution chest CT scans (HRCT)
Summary
Decreased diffusing capacity of the lung for carbon monoxide (DLCO) is observed in some idiopathic pulmonary arterial hypertension (IPAH) patients, but its clinical significance is uncertain. Conclusions: Low DLCO was a marker of worse functional capacity and increased risk of death in studied IPAH patients. The risk stratification in idiopathic pulmonary arterial hypertension (IPAH) patients is currently based on hemodynamic [1−4] and functional parameters such as: functional class [1, 4], distance of six-minute walking test [2, 3, 5], peak exercise oxygen consumption [6, 7]. The aim of the present study was to assess clinical correlates and prognostic significance of low DLCO in IPAH patients
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.